These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23991998)

  • 1. Cost-effectiveness of Korea's National Cervical Cancer Screening Program.
    Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
    Asian Pac J Cancer Prev; 2013; 14(7):4329-34. PubMed ID: 23991998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Cancer Screening Program for breast cancer in the Republic of Korea: is it cost-effective?
    Kang MH; Park EC; Choi KS; Suh M; Jun JK; Cho E
    Asian Pac J Cancer Prev; 2013; 14(3):2059-65. PubMed ID: 23679319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness outcomes of the national gastric cancer screening program in South Korea.
    Cho E; Kang MH; Choi KS; Suh M; Jun JK; Park EC
    Asian Pac J Cancer Prev; 2013; 14(4):2533-40. PubMed ID: 23725170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling cost-effectiveness of cervical cancer screening in Hungary.
    Vokó Z; Nagyjánosi L; Margitai B; Kövi R; Tóth Z; László D; Kaló Z
    Value Health; 2012 Jan; 15(1):39-45. PubMed ID: 22264970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon.
    Sharma M; Seoud M; Kim JJ
    Vaccine; 2017 Jan; 35(4):564-569. PubMed ID: 28017434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of prostate cancer screening test as a national cancer screening program in South Korea.
    Shin S; Kim YH; Hwang JS; Lee YJ; Lee SM; Ahn J
    Asian Pac J Cancer Prev; 2014; 15(8):3383-9. PubMed ID: 24870726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cost-utility analysis of cervical cancer screening and human papillomavirus vaccination in the Philippines.
    Guerrero AM; Genuino AJ; Santillan M; Praditsitthikorn N; Chantarastapornchit V; Teerawattananon Y; Alejandria M; Toral JA
    BMC Public Health; 2015 Jul; 15():730. PubMed ID: 26223975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada.
    Cromwell I; Gaudet M; Peacock SJ; Aquino-Parsons C
    BMC Health Serv Res; 2016 Jun; 16():206. PubMed ID: 27349646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of delivery structure on costs, screening and health promotional services in state level National Breast and Cervical Cancer Early Detection Programs.
    Trogdon JG; Ekwueme DU; Subramanian S; Miller JW; Wong FL
    Cancer Causes Control; 2019 Aug; 30(8):813-818. PubMed ID: 31187351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost.
    Suh YS; Lee J; Woo H; Shin D; Kong SH; Lee HJ; Shin A; Yang HK
    Cancer; 2020 Jan; 126(9):1929-1939. PubMed ID: 32031687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When public health intervention is not successful: Cost sharing, crowd-out, and selection in Korea's National Cancer Screening Program.
    Kim HB; Lee SM
    J Health Econ; 2017 May; 53():100-116. PubMed ID: 28340393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference of stage at cancer diagnosis by socioeconomic status for four target cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam cancer registries.
    Kweon SS; Kim MG; Kang MR; Shin MH; Choi JS
    J Epidemiol; 2017 Jul; 27(7):299-304. PubMed ID: 28279589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
    Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
    Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.
    Kim JJ; Campos NG; Sy S; Burger EA; Cuzick J; Castle PE; Hunt WC; Waxman A; Wheeler CM;
    Ann Intern Med; 2015 Oct; 163(8):589-97. PubMed ID: 26414147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries.
    Nelson S; Kim J; Wilson FA; Soliman AS; Ngoma T; Kahesa C; Mwaiselage J
    Value Health Reg Issues; 2016 Sep; 10():1-6. PubMed ID: 27881270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of economic aspects of cervical cancer screening strategies worldwide: discrepancy between economic analysis and policymaking.
    Nahvijou A; Hadji M; Marnani AB; Tourang F; Bayat N; Weiderpass E; Daroudi R; Sari AA; Zendehdel K
    Asian Pac J Cancer Prev; 2014; 15(19):8229-37. PubMed ID: 25339011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru.
    Goldie SJ; Levin C; Mosqueira-Lovón NR; Ortendahl J; Kim J; O'Shea M; Diaz Sanchez M; Mendoza Araujo MA
    Rev Panam Salud Publica; 2012 Dec; 32(6):426-34. PubMed ID: 23370186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Participation Rates for the National Cancer Screening Program in Korea, 2002-2012.
    Suh M; Song S; Cho HN; Park B; Jun JK; Choi E; Kim Y; Choi KS
    Cancer Res Treat; 2017 Jul; 49(3):798-806. PubMed ID: 27857022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Costs of population cervical cancer screening program in Poland between 2007-2009].
    Spaczyński M; Karowicz-Bilinska A; Kedzia W; Molińska-Glura M; Seroczyński P; Januszek-Michalecka L; Rokita W; Nowak-Markwitz E
    Ginekol Pol; 2010 Oct; 81(10):750-6. PubMed ID: 21117303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.